Patents by Inventor Katharine M. Wright

Katharine M. Wright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MANAbodies targeting tumor antigens and methods of using
    Patent number: 12674002
    Abstract: This document provides methods and materials for assessing a mammal having or suspected of having cancer and/or for treating a mammal having cancer. For example, molecules including one or more antigen-binding domains (e.g., a single-chain variable fragment (scFv)) that can bind to a modified peptide (e.g., a tumor antigen), as well as method for using such molecules, are provided.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: July 7, 2026
    Assignee: The Johns Hopkins University
    Inventors: Bert Vogelstein, Kenneth W. Kinzler, Emily Han-Chung Hsiue, Jacqueline Douglass, Michael S. Hwang, Alexander H. Pearlman, Nickolas Papadopoulos, Shibin Zhou, Brian J. Mog, Katharine M. Wright, Sandra B. Gabelli
  • MANABODIES TARGETING P53 TUMOR ANTIGENS AND METHODS OF USING
    Publication number: 20250034252
    Abstract: Described herein are methods and compositions for assessing a mammal having or suspected of having cancer and/or for treating a mammal having cancer. For example, molecules including one or more antigen-binding domains (e.g., a single-chain variable fragment (scFv)) that can bind to a modified peptide (e.g., a tumor antigen), as well as method for using such molecules, are provided.
    Type: Application
    Filed: December 15, 2022
    Publication date: January 30, 2025
    Inventors: Bert Vogelstein, Kenneth W. Kinzler, Nickolas Papadopoulos, Shibin Zhou, Sarah DiNapoli, Emily Han-Chung Hsiue, Brian J. Mog, Katharine M. Wright, Sandra B. Gabelli
  • MANAbodies TARGETING TUMOR ANTIGENS AND METHODS OF USING
    Publication number: 20230051847
    Abstract: This document provides methods and materials for assessing a mammal having or suspected of having cancer and/or for treating a mammal having cancer. For example, molecules including one or more antigen-binding domains (e.g., a single-chain variable fragment (scFv)) that can bind to a modified peptide (e.g., a tumor antigen), as well as method for using such molecules, are provided.
    Type: Application
    Filed: December 17, 2020
    Publication date: February 16, 2023
    Inventors: Bert Vogelstein, Kenneth W. Kinzler, Emily Han-Chung Hsiue, Jacqueline Douglass, Michael S. Hwang, Alexander Pearlman, Nickolas Papadopoulos, Shibin Zhou, Brian Mog, Katharine M. Wright, Sandra B. Gabelli